Co-produced with PendragonY
Why Invest in Healthcare and Biotech Closed-End Funds?
Tekla Healthcare Investors (HQH) has been an HDO holding for more than four years, and in April we upgraded it to a "Must Own", in the midst of the COVID-19 outbreak. As a closed-end fund that's primarily invested in healthcare industries, particularly focused on mid- to large-cap biotechnology and pharmaceutical growth companies, we thought the fund was positioned well to put your money at work for a good cause and also benefit from it. This is finding a cure for the COVID-19